Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

78 results about "Morphinans" patented technology

Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS.

Neuroprotective properties of dextrorotatory morphinans

InactiveUS20050256147A1Effective anti-ParkinsonismAvoid production cutsBiocideNervous disorderMorphinansNeuroprotection
The present application discloses a pharmaceutical composition for treating Parkinson's disease and psychotropic intoxication / abusive potential, which contains a morphinan compound.
Owner:KNU IND COOPERATION FOUND

Process for the preparation of morphine analogs via metal catalyzed n-demethylation/functionalization and intramolecular group transfer

The present application is directed to an efficient conversion of C-14 hydroxylated morphine alkaloids to various morphine analogs, such as naltrexone, naloxone and nalbuphone. One feature of this process is an intramolecular functional group transfer from the C-14 hydroxyl to the N-17 nitrogen atom following a palladium-catalyzed N-demethylation.
Owner:BROCK UNIVERSITY

Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans

Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.
Owner:MALLINCKRODT INC

Heterocycle-fused morphinans compounds, preparation method and use thereof

The invention discloses an aromatic or aliphatic heterocyclic condensed morphinan compound, a synthesis method thereof, and such applications thereof as opioid receptor agonist or anti-agonist in treating drug abuse and as novel painkiller. The general structural formula of the compound is shown in (I), wherein, R is H, straight chain or branch chain alkyl of C1 to C10, aromatic group or aliphatic heterocyclic or non-heterocyclic substituted alkyl; X is H, -OH, alkoxy, amido, substituted amido, carboxyl, ester group, aminoacyl; Y is H, -OH, alkoxyl, amido, substituted amido, etc., and Z is various substituted pentagon, hexagon or substituted pentagon, hexagon aromatic and aliphatic heterocycle.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products